Viewing Study NCT06257693


Ignite Creation Date: 2025-12-25 @ 1:03 AM
Ignite Modification Date: 2026-04-11 @ 6:38 AM
Study NCT ID: NCT06257693
Status: RECRUITING
Last Update Posted: 2024-06-28
First Post: 2023-12-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
Sponsor: Alessa Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module